2022Journal of The Electrochemical SocietyOpen access

Review—Progress in Electroanalysis of p53, CEA, and CA19–9

Ruxandra‐Maria Ilie‐Mihai, Raluca‐Ioana Stefan‐van Staden, Jacobus Frederick van Staden

Open full text 4 citations

Abstract

Screening tests for panels of biomarkers such as the panel comprising p53, CEA, and CA19–9 facilitated early diagnosis of cancers and improvement of the quality of life. In this review, diverse electrochemical sensors used for the assay of p53, CEA, and CA 19–9 in biological samples are shown. Different methods of analysis such as differential pulse voltammetry, electrochemical impendance spectroscopy, chronoamperometry, and stochastic method were used for the assay of one biomarker (differential pulse voltammetry, chronoamperometry) or for the assay of a panel of biomarkers comprising p53, CA19–9, and CEA using stochastic method. The lowest limits of determination were obtained using the stochastic method; they were of fg ml −1 /fU ml −1 magnitude order.

Open-access reader

About this research paper

What this paper is about

Screening tests for panels of biomarkers such as the panel comprising p53, CEA, and CA19–9 facilitated early diagnosis of cancers and improvement of the quality of life. In this review, diverse electrochemical sensors used for the assay of p53, CEA, and CA 19–9 in biological samples are shown. Different methods of analysis such as differential pulse voltammetry, electrochemical impendance spectroscopy, chronoamperometry, and stochastic method were used for the assay of one biomarker (differential pulse voltammetry, chronoamperometry) or for the assay of a panel of biomarkers comprising p53, CA19–9, and CEA using stochastic method. The lowest limits of determination were obtained using the stochastic method; they were of fg ml −1 /fU ml −1 magnitude order.

Why it matters

OpenAlex reports 4 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Screening tests for panels of biomarkers such as the panel comprising p53, CEA, and CA19–9 facilitated early diagnosis of cancers and improvement of the quality of life. In this review, diverse electrochemical sensors used for the assay of p53, CEA, and CA 19–9 in biological samples are shown. Different methods of analysis such as differential pulse voltammetry, electrochemical impendance spectroscopy, chronoamperometry, and stochastic method were used for the assay of one biomarker (differential pulse voltammetry, chronoamperometry) or for the assay of a panel of biomarkers comprising p53, CA19–9, and CEA using stochastic method. The lowest limits of determination were obtained using the stochastic method; they were of fg ml −1 /fU ml −1 magnitude order.

Key concepts: Chronoamperometry, Differential pulse voltammetry, Biomarker, Cyclic voltammetry, Voltammetry, Chemistry, Analytical Chemistry (journal), Electrochemistry

Related papers

Back to paper searchBrowse research topicsOriginal source
Review—Progress in Electroanalysis of p53, CEA, and CA19–9 — Research Paper | ScholarLens